Therapy News and Research

RSS

METOZOLV drug approved for treating gastroesophageal reflux disease

Wilmington Pharmaceuticals announced today the U.S. Food and Drug Administration (FDA) has granted marketing approval for METOZOLV ODT (metoclopramide HCl), an orally disintegrating formulation of metoclopramide for the treatment of gastroesophageal reflux disease (GERD) and diabetic gastroparesis.

10 Sep 2009

Season's Practice launches women health and wellness solutions in Northeast Ohio

Season's Practice has opened its doors to women in Northeast Ohio who are seeking alternative health and wellness solutions to improve their overall health and well-being.

10 Sep 2009

New treatment strategies for multiple sclerosis

The drawback in the new immunotherapies in multiple sclerosis (MS) includMe severe infections that can be fatal. For example, treatment with natalizumab, which reduces the immune surveillance of the brain, can lead to the development of progressive multifocal leukoencephalopathy (PML), a typically fatal form of viral encephalitis.

10 Sep 2009

Research on the role of microRNAs in cellular processes

RNAs, serving as a mere intermediary between DNA and proteins, were long regarded as a poor relation by researchers, attracting little interest. However, following the discovery of small RNAs known as microRNAs, they have increasingly been moving into the limelight. MicroRNAs bind to messenger RNA (mRNA), thereby regulating the translation of genes into proteins.

10 Sep 2009

Cempra commences Phase 2/3 clinical study of CEM-102 for treating acute bacterial skin structure infections

Cempra Pharmaceuticals today announced that enrollment is underway in an adaptive design Phase 2/3 clinical study with CEM-102 for patients suffering from acute bacterial skin structure infections (ABSSI). CEM-102 is an oral antibiotic with an established record of treating staphylococcal infections outside the United States, including those due to methicillin-resistant Staphylococcus aureus (MRSA).

10 Sep 2009

Special issue of Optometry & Vision Development explores autism

Autism. What is its cause? How does it affect brain anatomy, electrophysiology, visual function and perception? What must we do to meet the needs of these patients? How can optometrists as health care providers be in the vanguard for screening for this spectrum of disorders?

10 Sep 2009

Non-invasive CR-2000 Research System to be used in START clinical trial

Hypertension Diagnostics, Inc., today announced that its non-invasive HDI/PulseWave CR-2000 Research System (CR-2000) has been selected for use in the Strategic Timing of AntiRetroviral Treatment (START) substudy on Arterial Elasticity that will examine blood vessel function and cardiovascular risk during HIV infection.

10 Sep 2009

New treatment for facial wrinkles combines high-intensity light and green tea extract lotion

Scientists in Germany are reporting a major improvement in their potential new treatment for facial wrinkles that could emerge as an alternative to Botox and cosmetic surgery. The non-invasive technique combines high-intensity light from light-emitting diodes (LEDs) and a lotion made of green tea extract. It works ten times faster than a similar anti-wrinkle treatment that uses LEDs alone, the researchers say.

10 Sep 2009

Nanobio hybrids for brain cancer therapy

In an advance toward better treatments for the most serious form of brain cancer, scientists in Illinois are reporting development of the first nanoparticles that seek out and destroy brain cancer cells without damaging nearby healthy cells. The study is scheduled for the Sept. 9 issue of ACS' Nano Letters, a monthly journal.

10 Sep 2009

Board-certified vascular surgeon joins VIVA

Virginia Interventional and Vascular Associates (VIVA) and its parent group, Radiologic Associates of Fredericksburg (RAF) Ltd., announce that Victor J. D'Addio, M.D., FACS, has joined the practice. Dr. D'Addio is a board-certified vascular surgeon. Together, the practice offers streamlined services for vascular patients and referring physicians -- from office-based vascular testing to minimally invasive treatments and traditional surgery.

10 Sep 2009

Clinical trial reveals RENOVA topical treatment cream shows continuous improvement

In 2008, the global anti-aging skincare market approached $15 billion, with 32 percent of U.S. facial skincare product launches boasting anti-aging claims many over-the-counter products are claiming to achieve comparable benefits as prescription anti-aging treatments.

10 Sep 2009

South East Asian health ministers adopt declaration to improve disaster preparedness, address childhood diarrhea

Health ministers from 11 member states in the WHO's South East Asian region on Tuesday at the 62nd session of the WHO Regional Committee for South East Asia adopted the Kathmandu Declaration on Protecting Health Facilities from Disasters, which commits them to make health facilities better prepared for health emergencies, Republica reports.

10 Sep 2009

Patient enrollment completed in Phase 2b clinical trial for Pyridorin

NephroGenex, Inc., a privately held drug development company focusing on kidney disease, today announced the completion of patient enrollment in its Phase 2b clinical trial (PYR-210) studying the safety and efficacy of its lead drug candidate Pyridorin (pyridoxamine dihydrochloride) in type 2 diabetic patients with overt diabetic nephropathy. Three hundred and seventeen (317) patients have been randomized.

10 Sep 2009

Preventive-care TB therapy is cost-effective for patients

University of Alabama at Birmingham (UAB) researchers have found that the cost of preventive antibiotic tuberculosis (TB) therapy for patients infected by human immunodeficiency virus (HIV) is generally less expensive than the reported cost of treating newly confirmed TB cases.

10 Sep 2009

Clinical study investigates laboratory and clinical implications of proton pump inhibitor drugs

Fears about the cancer causing effects of the second most prescribed group of drugs in the Western world have been put to rest, following the largest ever study into their use.

10 Sep 2009

Miracles of the immune system discussed at the 2nd European Congress of Immunology

"I think it will not surprise you if I say that the immune system is one of our most important organ systems. Its relevance is obvious if only for the fact that it has been reinvented several times throughout the evolution of life," says Professor Andreas Radbruch, President of the German Society of Immunology and Director of the Deutsches Rheuma-Forschungszentrum, Berlin. He lectured about the miracle of our immune system at the Opening Press Conference of the 2nd European Congress of Immunology.

10 Sep 2009

Promega unveils Maxwell 16 Viral Total Nucleic Acid Purification Kit

Promega announces the release of the Maxwell 16 Viral Total Nucleic Acid Purification Kit which, among other labs, currently serves the OCA Hospital in Mexico for H1N1 clinical research.

10 Sep 2009

Aperio Technologies forges alliance with HistoRx to provide an integrated whole-slide imaging system

Aperio Technologies, Inc., (Aperio), a global leader in digital pathology for the healthcare and life sciences industry, and HistoRx, Inc., (HistoRx), a leader in the emerging field of tissue-based assays for targeted patient treatment, have entered into a partnership to provide an integrated solution for whole-slide imaging with fluorescence.

10 Sep 2009

Mentally ill smokers also benefit from treatment, says research paper

People with mental illnesses such as depression and anxiety are the heaviest smokers in the country, but their doctors are afraid to ask them to quit. They assume that if their patients try to quit smoking, their mental disorders will get worse.

9 Sep 2009

ARUP Laboratories' scientist receives grant to research HIV therapies

ARUP Laboratories, a national clinical and anatomic pathology reference laboratory and a leader in innovative laboratory research and development, announced that ARUP's Tanya Sandrock, PhD, Research & Development scientist, received a prestigious National Institutes of Health (NIH) grant to research additional HIV therapies.

9 Sep 2009

Therapy News and Research

METOZOLV drug approved for treating gastroesophageal reflux disease

Season's Practice launches women health and wellness solutions in Northeast Ohio

New treatment strategies for multiple sclerosis

Research on the role of microRNAs in cellular processes

Cempra commences Phase 2/3 clinical study of CEM-102 for treating acute bacterial skin structure infections

Special issue of Optometry & Vision Development explores autism

Non-invasive CR-2000 Research System to be used in START clinical trial

New treatment for facial wrinkles combines high-intensity light and green tea extract lotion

Nanobio hybrids for brain cancer therapy

Board-certified vascular surgeon joins VIVA

Clinical trial reveals RENOVA topical treatment cream shows continuous improvement

South East Asian health ministers adopt declaration to improve disaster preparedness, address childhood diarrhea

Patient enrollment completed in Phase 2b clinical trial for Pyridorin

Preventive-care TB therapy is cost-effective for patients

Clinical study investigates laboratory and clinical implications of proton pump inhibitor drugs

Miracles of the immune system discussed at the 2nd European Congress of Immunology

Promega unveils Maxwell 16 Viral Total Nucleic Acid Purification Kit

Aperio Technologies forges alliance with HistoRx to provide an integrated whole-slide imaging system

Mentally ill smokers also benefit from treatment, says research paper

ARUP Laboratories' scientist receives grant to research HIV therapies

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News